Abstract:15044 Background: The objectives of this are to detect the serum protein fingerprints of postoperative colorectal cancer patients by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and ProteinChip, to screen cancer progressive biomarkers. Methods: Between April 2002 and April 2005, seventy-two postoperative CRC patients with curative resectable colorectal cancer were followed-up. At a mean follow-up of 16 months, 42 patients diagnosed as postoperative recurrences or metastases and 30 patients diagnosed as no postoperative recurrences or metastases. The serum protein fingerprints of the 72 samples were detected. The data were pretreated and the discrepant proteins were screened to identify cancer progressive biomarkers. The protein fingerprints of the 30 patients survived free from cancer after their operations and the 42 patients with postoperative recurrences and metastases were compared by Biomarker Wizard 3.2.0. software and SPSS 13.0 software. Results: Ten discrepant proteins were screened in the comparison (P<0.05). The expression of m/z: 5908, 28092, 5341, 2957and 8566Da of the 30 patients who survived free from cancer after their operations were higher than that of the patients with cancer progression after their operations (P<0.05). Whereas, five proteins (m/z: 2107, 6114, 2131, 2162 and 2389 Da) were up regulated when cancer progression than those without cancer progression (P<0.05). Using SPSS 13.0 software, 5908 m/z protein was selected whose AUC values were more than 0.7. Gamma-CTF (50) protein may be the cancer progression biomarker whose MW is 5908Da. Conclusions: The method showed great potential for the screening postoperative colorectal cancer patients. It is worth studying further. Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Expert Testimony Other Remuneration Funded by the National Natural Science Foundation of China (Grant Number: 30471987), The National Natural Science Foundation of China (Grant Number: 30471987)

Biomarkers Screening Between Preoperative and Postoperative Patients in Pancreatic Cancer.

Ultra-Performance Liquid Chromatography Coupled with Quadrupole Time-Of-Flight Mass Spectrometry-Based Metabolic Profiling of Human Serum Prior to and Following Radical Resection of Colorectal Carcinoma

Screening Serum Biomarkers for Pancreatic Cancer by Serum Proteomics Techniques

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

Screening for Protein Markers from Serum of Patients with Pancreatic Carcinoma by Protein Finger Printing Technique

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis

[Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]

Construction of protein profiling models for diagnosis of pancreatic carcinoma

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Elevated Expression of Exosomal Microrna-21 As a Potential Biomarker for the Early Diagnosis of Pancreatic Cancer Using a Tethered Cationic Lipoplex Nanoparticle Biochip.

[Application of Serum Protein Profiling in Diagnosis, Prognosis and Evaluation of Curative Effect of Pancreatic Adenocarcinoma].

Identification of a six‐miRNA panel in serum benefiting pancreatic cancer diagnosis

Proteomics Analysis of Serum Protein Profiling in Pancreatic Cancer Patients by DIGE: Up-Regulation of Mannose-Binding Lectin 2 and Myosin Light Chain Kinase 2

The Application of Serum Protein Fingerprints in the Postoperative Follow-Up of Colorectal Cancer

Preliminary study on proteomics of gastric carcinoma and its clinical significance.

Diagnostic and Prognostic Application of Proteomic Patterns in Breast Cancer

A New Panel of Pancreatic Cancer Biomarkers Discovered Using a Mass Spectrometry-Based Pipeline.

Biomarker Discovery of Colorectal Mucinous Adenocarcinoma by Fingerprint and Support Vector Machine

Novel serum protein biomarker panel for early diagnosis of pancreatic cancer

Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer